TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT06160830 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06160830 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study NCT06160830 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT06160830 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT06160830 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06160830 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04861727 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05242822 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT05242822 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study NCT06435247 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05459129 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06437067 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06437067 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT04856176 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04856176 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06335355 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study NCT06335355 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00076518 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT06039592 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00214084 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05441956 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05441956 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT05438446 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05438446 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05257343 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06061224 — Safety Biomarker (SAF): IL-6 and IL-10
Study NCT06216249 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05770544 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT05561985 — Predictive Biomarker (PRD): STAT1 mRNA
Genes: STAT1
Study NCT06568146 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06299176 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06299176 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT05913063 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06509477 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04666038 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06530550 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT05436106 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study NCT04609319 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05218226 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT06182696 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT04872751 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04872751 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05229770 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study NCT05109260 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT05596526 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT06037239 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT05517798 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT06360549 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Matrix metalloproteinase 3
Genes: MMP3; STMY1
Study NCT04844086 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06522971 — Predictive Biomarker (PRD): NLRP1 mRNA
Genes: NLRP1; CARD7; DEFCAP; KIAA0926; NAC; NALP1
Study NCT06464861 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06574347 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT06531460 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05380102 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01141829 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05031468 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05382364 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05382364 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06573216 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06662721 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06662721 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT05282641 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05185297 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06663527 — Predictive Biomarker (PRD): CPD mRNA
Genes: CPD
Study NCT06664008 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06664008 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06664008 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT06664008 — Safety Biomarker (SAF): Interleukin 12
Study NCT06663267 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05167903 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05167903 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT05242965 — Predictive Biomarker (PRD): SOX2 mRNA
Genes: SOX2
Study NCT05242965 — Predictive Biomarker (PRD): CDH3 mRNA
Genes: CDH3; CDHP
Study NCT05242965 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT05242965 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06339567 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT05371145 — Predictive Biomarker (PRD): Hypoxia-inducible factor 1-alpha
Genes: HIF1A; BHLHE78; MOP1; PASD8
Study NCT05724004 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06469047 — Predictive Biomarker (PRD): PNOC mRNA
Genes: PNOC; OFQ
Study NCT02718105 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-C
Genes: HLA-JY3, D6S204, PSORS1
Study NCT04731675 — Predictive Biomarker (PRD): CSF1 mRNA
Genes: CSF1
Study NCT06158828 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05001672 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05779566 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06507384 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05850871 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study NCT06282328 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06210243 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05259449 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05727423 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06515860 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT06204393 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT00018109 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06332300 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04713748 — Predictive Biomarker (PRD): SST mRNA
Genes: SST
Study NCT05470699 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05120544 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00002312 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04364620 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05500976 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06103994 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05192564 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05306912 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06379997 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05867394 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05122182 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study NCT06396117 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT06335771 — Predictive Biomarker (PRD): TFEB mRNA
Genes: TFEB; BHLHE35
Study NCT05336513 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04708860 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06089941 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04590547 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT04590547 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05462639 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05462639 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06065306 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04831853 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06283420 — Predictive Biomarker (PRD): Hypoxia-inducible factor 1-alpha
Genes: HIF1A; BHLHE78; MOP1; PASD8
Study NCT05307809 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT06430372 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06430372 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05474144 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04816318 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05486949 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05747326 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06403098 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05906017 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06547515 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05007873 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT05007873 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT06664671 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06663761 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04473040 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04830878 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT05990049 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06269237 — Predictive Biomarker (PRD): LTA mRNA
Genes: LTA; TNFB; TNFSF1
Study NCT06165029 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04866134 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT06047496 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05435729 — Safety Biomarker (SAF): DRD2
Study NCT05768737 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05156255 — Predictive Biomarker (PRD): FUT2 mRNA
Genes: FUT2; SEC2
Study NCT05184205 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05905939 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05905939 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06409754 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT05404217 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05319132 — Predictive Biomarker (PRD): ALPK1 mRNA
Genes: ALPK1; KIAA1527; LAK
Study NCT05245877 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT06334874 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05977166 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05979168 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06018688 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05991141 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT06340490 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06523062 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05369481 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT05394337 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT05416307 — Predictive Biomarker (PRD): SIRPA mRNA
Genes: SIRPA; BIT; MFR; MYD1; PTPNS1; SHPS1; SIRP
Study NCT05315388 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06446271 — Predictive Biomarker (PRD): TTN mRNA
Genes: TTN
Study NCT06446271 — Predictive Biomarker (PRD): MYBPC3 mRNA
Genes: MYBPC3
Study NCT06446271 — Predictive Biomarker (PRD): LMNA mRNA
Genes: LMNA; LMN1
Study NCT06446271 — Predictive Biomarker (PRD); Safety Biomarker (SAF): FLNC mRNA
Genes: FLNC; ABPL; FLN2
Study NCT06446271 — Predictive Biomarker (PRD): DSP mRNA
Genes: DSP
Study NCT04981288 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05081739 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04797806 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06458010 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT05884736 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study NCT05928702 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05225259 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT06256991 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT06256991 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06341010 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study NCT04862091 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT06027346 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT00866983 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT06505486 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study NCT04778800 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04778800 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05710653 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06572800 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06572800 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05896813 — Predictive Biomarker (PRD): DNMT1 mRNA
Genes: DNMT1; AIM; CXXC9; DNMT
Study NCT05503888 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04991350 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05278156 — Predictive Biomarker (PRD): PDE10A mRNA
Genes: PDE10A
Study NCT00000838 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05772910 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05883254 — Predictive Biomarker (PRD): PUM1 mRNA
Genes: PUM1; KIAA0099; PUMH1
Study NCT06664645 — Predictive Biomarker (PRD): LHB mRNA
Genes: LHB
Study NCT05747118 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06662877 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT06608069 — Predictive Biomarker (PRD): PTBP2 mRNA
Genes: PTBP2; NPTB; PTB; PTBLP
Study NCT06270303 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT04432610 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05829083 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05173701 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study NCT05173701 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05488002 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05058846 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT05561686 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04955938 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT04955938 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT06450327 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT06450327 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06450327 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06480799 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04913623 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04913623 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04913623 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04742738 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05515432 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06480435 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05496647 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06001619 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT04536350 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study NCT05749692 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05729360 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06485661 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05867784 — Predictive Biomarker (PRD): UST mRNA
Genes: UST; DS2ST
Study NCT06023641 — Predictive Biomarker (PRD): CEP72 mRNA
Genes: CEP72; KIAA1519
Study NCT06481150 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT05378893 — Predictive Biomarker (PRD): GCGR mRNA
Genes: GCGR
Study NCT05750693 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT03879304 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT03879304 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study NCT04878692 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05286437 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT05286437 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT05286437 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT05286437 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT05286437 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05286437 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05286437 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05286437 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06267066 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT05639998 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05655780 — Safety Biomarker (SAF): Bacterial beta-glucuronidase
Genes: uidA; gurA; gusA; b1617; JW1609
Study NCT04847050 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04847050 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04847050 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04889092 — Predictive Biomarker (PRD): Hypoxia-inducible factor 1-alpha
Genes: HIF1A; BHLHE78; MOP1; PASD8
Study NCT04889092 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05830877 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study NCT01381289 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06269419 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT06269419 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06269419 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06269419 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT06269419 — Safety Biomarker (SAF): Urinary microalbumin
Study NCT05264142 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT04720534 — Predictive Biomarker (PRD): APOC3 mRNA
Genes: APOC3
Study NCT04720534 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05382910 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT05955677 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04698798 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04698798 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06000605 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06000605 — Safety Biomarker (SAF): BDNF
Study NCT05732922 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05011721 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05738720 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05932368 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06001294 — Predictive Biomarker (PRD): APELA mRNA
Genes: APELA; ELA; TDL
Study NCT06001294 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT04632940 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06209723 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05871918 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL